Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Issues
2011
November/December 2010, Vol 1, No 6
November/December 2010, Vol 1, No 6
Perception Versus Actual Testing for KRAS
By
Janna Radtchenko
Oncology
November/December 2010, Vol 1, No 6
Both practice guidelines and thought leaders increasingly recommend biomarker tests for optimization of cancer care; there is, however, a gap between these recommendations, the way physicians practice, and the way they think they practice.
Read Article
Teasing Out Value in Healthcare Spending Variations
Value Propositions
,
Value Peer-spectives
November/December 2010, Vol 1, No 6
At the request of the US Secretary of Health and Human Services, the Institute of Medicine (IOM) will conduct a study on national variation in healthcare spending and utilization for individuals with Medicare, Medicaid, private insurance, or no insurance.
Read Article
Shedding Tiers for Better Value
Value Propositions
,
Value Peer-spectives
November/December 2010, Vol 1, No 6
Read Article
Blood-Use Program Injects Clinical, Fiscal Control
Value Propositions
,
Value Peer-spectives
November/December 2010, Vol 1, No 6
A blood-use protocol program at Loyola University Hospital in Chicago has lowered the amount of blood products transfused per patient, which in turn has led to greater patient safety and lowered costs, according to research presented at the College of American Pathologists annual meeting in Chicago.
Read Article
Free Is Good, Not Great, When It Comes to Screening
Value Propositions
,
Value Peer-spectives
November/December 2010, Vol 1, No 6
Removing payment for health insurance deductibles leads to increased, although modest, improvements in the rates of screening for conditions such as cancer and elevated cholesterol (Meeker D, et al. Health Serv Res. 2010. Online doi:10.1111/j.1475-6773.2010.01188.x).
Read Article
CT Screening Shows Dramatic Benefit in Lung Cancer
Value Propositions
,
Value Peer-spectives
November/December 2010, Vol 1, No 6
A study comparing the use of computed tomography (CT) versus standard chest x-rays for screening those at high risk for lung cancer found that CT screening resulted in 20% fewer deaths from the disease.
Read Article
Colorectal Cancer Screening: Spend Now to Save Later
Value Propositions
,
Value Peer-spectives
November/December 2010, Vol 1, No 6
Spending money on colorectal cancer screening programs that target the pre-Medicare population (those between 50 and 64 years of age) is necessary to reduce the costs of colorectal cancer in the Medicare program, according to research presented at the American College of Gastroenterology’s 75th Annual Scientific Meeting in San Antonio, TX.
Read Article
Researchers Bark Up New Tree to Manufacture Cancer Drug
Value Propositions
,
Value Peer-spectives
November/December 2010, Vol 1, No 6
Paclitaxel (Taxol), which is produced from the bark of the yew, may become cheaper and easier to produce now that researchers have isolated and grown stem cells from that tree (Nat Biotechnol.
Read Article
Filling in Funds Around NICE Gaps
Value Propositions
,
Value Peer-spectives
November/December 2010, Vol 1, No 6
The United Kingdom’s (UK) Department of Health has pledged £250 million toward a Cancer Drugs Fund that will pay for new treatments not available in the state-funded health system.
Read Article
Price-Cutting May Spur Canadian Use of Cervical Vaccine
Value Propositions
,
Value Peer-spectives
November/December 2010, Vol 1, No 6
Read Article
Page 1 of 3
1
2
3
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma